<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>Catalytic Mechanism of Vaccinia Virus Protein in VP39 in 2'-O-Methylation of the mRNA 5' Cap Structure</AwardTitle>
<AwardEffectiveDate>04/01/2001</AwardEffectiveDate>
<AwardExpirationDate>03/31/2005</AwardExpirationDate>
<AwardTotalIntnAmount>330000.00</AwardTotalIntnAmount>
<AwardAmount>335000</AwardAmount>
<AwardInstrument>
<Value>Continuing grant</Value>
</AwardInstrument>
<Organization>
<Code>08070400</Code>
<Directorate>
<Abbreviation>BIO</Abbreviation>
<LongName>Direct For Biological Sciences</LongName>
</Directorate>
<Division>
<Abbreviation>MCB</Abbreviation>
<LongName>Div Of Molecular and Cellular Bioscience</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Parag R. Chitnis</SignBlockName>
</ProgramOfficer>
<AbstractNarration>0091260&lt;br/&gt;Gershon&lt;br/&gt;Recently, the P.I. collaborated in determining a high-resolution crystal structure for a prototypical nucleic acid sugar methyltransferase complexed with its cofactor and RNA substrate. This enzyme, vaccinia virus protein VP39, methylates messenger RNA at the 2'OH of a ribose within the 5' end cap structure. The structural data afford an unusual opportunity to identify the chemical processes underlying nucleic acid ribose methylation. Atomic-scale examination of the enzyme's catalytic center with bound substrate and cofactor suggests a mechanism whereby the charged oxygen generated by deprotonation of the target ribose hydroxyl attacks the trivalent sulfur of the methyl-donating cofactor (S-adenosylmethionine), effecting displacement of cofactor-product (S-adenosylhomocysteine). Although the sidechain of VP39 residue Lysine 175 is well-positioned to effect deprotonation of the hydroxyl, lysine 175's pKa would need to be depressed ~three orders of magnitude. The sidechain of a neighboring residue, arginine 209 may cause this depression to occur, and aspartate 138 may act as the proton sink (assuming a pKa elevation in the aspartate 138 sidechain). &lt;br/&gt;To determine whether the target hydroxyl is indeed deprotonated in the context of VP39, NMR will be used to investigate hydroxyl-deprotonation of the VP39-bound isotope-enriched RNA substrate. Next, VP39 sidechain pKa values will be examined after (1) modification of a unique-cysteine-175 substitution mutant with an isotope-enriched aminoethylation reagent and/or (2) generating proteins in which lysine 175, arginine 209 or aspartate 138 each comprise half of a uniquely 13C/15N enriched dipeptide. In combination with mutagenesis, these selective labeling strategies will facilitate the determination of sidechain pKa in the presence and absence of cofactor-product.&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>03/06/2001</MinAmdLetterDate>
<MaxAmdLetterDate>03/21/2003</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0091260</AwardID>
<Investigator>
<FirstName>Paul</FirstName>
<LastName>Gershon</LastName>
<EmailAddress>pgershon@uci.edu</EmailAddress>
<StartDate>03/06/2001</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Texas A&amp;M Research Foundation</Name>
<CityName>College Station</CityName>
<ZipCode>778454375</ZipCode>
<PhoneNumber>9798626777</PhoneNumber>
<StreetAddress>400 Harvey Mitchell Parkway, S</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Texas</StateName>
<StateCode>TX</StateCode>
</Institution>
<ProgramElement>
<Code>1166</Code>
<Text>MOLECULAR BIOCHEMISTRY</Text>
</ProgramElement>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9183</Code>
<Text>GENERAL FOUNDATIONS OF BIOTECHNOLOGY</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
<ProgramReference>
<Code>SMET</Code>
<Text>SCIENCE, MATH, ENG &amp; TECH EDUCATION</Text>
</ProgramReference>
</Award>
</rootTag>
